Jaguar Health, Inc.
JAGX
$2.58
$0.010.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.73M | -38.49M | -37.74M | -35.67M | -38.32M |
| Total Depreciation and Amortization | 2.29M | 2.36M | 2.36M | 2.39M | 2.45M |
| Total Amortization of Deferred Charges | 0.00 | 274.00K | 1.98M | 9.07M | 12.20M |
| Total Other Non-Cash Items | 9.32M | 9.49M | 9.29M | 5.07M | 4.40M |
| Change in Net Operating Assets | -1.54M | -3.01M | -4.90M | -10.32M | -11.07M |
| Cash from Operations | -29.65M | -29.38M | -29.01M | -29.46M | -30.34M |
| Capital Expenditure | -16.00K | -16.00K | -16.00K | -16.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -215.00K | -215.00K | -- | -- | -- |
| Cash from Investing | -231.00K | -231.00K | -16.00K | -16.00K | -- |
| Total Debt Issued | 3.45M | -- | -- | -- | -- |
| Total Debt Repaid | -724.00K | -708.00K | -1.15M | -926.00K | -889.00K |
| Issuance of Common Stock | 21.31M | 32.07M | 39.12M | 36.78M | 26.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 623.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -132.00K | -157.00K | 1.05M | 1.05M | 971.00K |
| Cash from Financing | 23.90M | 31.20M | 39.02M | 36.90M | 27.68M |
| Foreign Exchange rate Adjustments | 1.00K | -54.00K | 46.00K | -5.00K | -36.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.98M | 1.53M | 10.04M | 7.42M | -2.70M |